New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|June 1, 2002
Supplements and Featured Publications
- Protection Across the Cardiovascular Continuum: What Can Be Done for Patients at Risk?
- Volume 8
- Issue 9 Suppl
Cardioprotection: What Is It? Who Needs It?
Author(s)William B. Kannel, MD, MPH
Advertisement
Articles in this issue
over 24 years ago
Introductionover 24 years ago
Statins as Cardioprotective Agentsover 24 years ago
ACE Inhibitors as Cardioprotective Agentsover 24 years ago
Role of Antiplatelet Agents in Cardioprotectionover 24 years ago
Call to ActionAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant Plus Abemaciclib for Breast Cancer
2
Lung Cancer Progress Drives Down US Cancer Death Rates
3
Higher CPAP Adherence Linked With Lower Mortality Risk in OSA
4
All 50 States Apply for CMS's GENEROUS Model, With $64.3B in Savings Projected
5